Related Experiment Video
Updated: Aug 8, 2026

Isolation of Atrial Myocytes from Adult Mice
Published on: July 25, 2019
Cardiac production of C-type natriuretic peptide in heart failure
Silvia Del Ry1, Maristella Maltinti, Marcello Piacenti
1Institute of Clinical Physiology, National Research Council, Pisa, Italy.
Insights
The heart produces C-type natriuretic peptide (CNP) in patients with chronic heart failure. This study confirms elevated CNP levels in coronary sinus blood compared to aorta blood, supporting cardiac CNP production.
Area of Science:
- Cardiology
- Endocrinology
- Biochemistry
Background:
- Cardiac production of C-type natriuretic peptide (CNP) in chronic heart failure (CHF) patients was previously suggested.
- Measuring plasma CNP levels in aortic root and coronary sinus samples indicated cardiac CNP release.
- This study aimed to re-evaluate cardiac CNP production in CHF patients.
Purpose of the Study:
- To confirm and strengthen the hypothesis of cardiac C-type natriuretic peptide production in patients with chronic heart failure.
- To re-assess cardiac CNP production by analyzing blood samples from the coronary sinus and aorta.
Main Methods:
- Cardiac CNP production was evaluated in 6 patients with chronic heart failure.
- Blood samples were collected from the coronary sinus and aorta during cardiac catheterization.
- CNP levels were measured using a specific immunometric assay after plasma sample extraction.
Main Results:
- Significantly higher CNP levels were observed in coronary sinus blood (7.8 ± 1.3 pg/ml) compared to aorta blood (6.1 ± 1.5 pg/ml) (P = 0.034).
- These findings align with previous research.
- Combined data from this and a prior study (n=15) showed a significant increase in CNP concentrations between the two sites (P = 0.002).
Conclusions:
- The study results provide further evidence supporting the hypothesis that the heart produces C-type natriuretic peptide in patients suffering from chronic heart failure.
- Cardiac CNP production is a significant factor in the pathophysiology of chronic heart failure.
Background:
C-type natriuretic peptide production by the heart in patients with chronic heart failure has recently been demonstrated by measuring the difference in C-type natriuretic peptide plasma levels between the aortic root and coronary sinus samples. To assess this previous relevant observation, we re-evaluated the cardiac production of C-type natriuretic peptide, thus increasing the total number of patients studied. In light of the difficulty in recruiting patients with these characteristics, this kind of study can be performed with a small number of subjects.
Methods:
Cardiac production of C-type natriuretic peptide was evaluated in a subset (n = 6) of patients, referred to our institute for the evaluation of chronic heart failure. C-type natriuretic peptide was measured in the coronary sinus and in aorta blood collected during right and left heart catheterization using a specific immunometric assay, after solid-phase extraction of plasma samples.
Results:
Significantly higher C-type natriuretic peptide levels were found in the coronary sinus than in aorta blood (7.8 +/- 1.3 versus 6.1 +/- 1.5 pg/ml, P = 0.034) and our results were in accordance with previous ones. Analysing as a whole the data gathered in the two studies, a noteworthy significant increase was observed (n = 15, P = 0.002) between the C-type natriuretic peptide concentrations in the two sites.
Conclusions:
The results of the present study strengthen the hypothesis that C-type natriuretic peptide is produced by the heart in patients with chronic heart failure.
Related Concept Videos
Heart Failure II: Pathophysiology
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Pathophysiology of Heart Failure
Heart Failure VII: Nursing Interventions
Cardiomyopathy VI: Nursing Management
